Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.
2.

The Use of Melatonin by Children: Parents' Perspectives.

Waldron AY, Spark MJ, Dennis CM.

J Clin Sleep Med. 2016 Oct 15;12(10):1395-1401.

PMID:
27568907
3.

Identification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes.

Frye RE, Rossignol DA.

Clin Med Insights Pediatr. 2016 Jun 15;10:43-56. doi: 10.4137/CMPed.S38337. Review.

4.

A Short Review on the Current Understanding of Autism Spectrum Disorders.

Park HR, Lee JM, Moon HE, Lee DS, Kim BN, Kim J, Kim DG, Paek SH.

Exp Neurobiol. 2016 Feb;25(1):1-13. doi: 10.5607/en.2016.25.1.1. Review.

5.

Is suvorexant a better choice than alternative hypnotics?

Kripke DF.

F1000Res. 2015 Aug 3;4:456. doi: 10.12688/f1000research.6845.1.

6.

Treatment for Sleep Problems in Children with Autism and Caregiver Spillover Effects.

Tilford JM, Payakachat N, Kuhlthau KA, Pyne JM, Kovacs E, Bellando J, Williams DK, Brouwer WB, Frye RE.

J Autism Dev Disord. 2015 Nov;45(11):3613-23. doi: 10.1007/s10803-015-2507-5.

7.

Melatonin in Children with Autism Spectrum Disorders: How Does the Evidence Fit Together?

Veatch OJ, Goldman SE, Adkins KW, Malow BA.

J Nat Sci. 2015;1(7):e125.

8.

Melatonin Treatment in Children with Developmental Disabilities.

Schwichtenberg AJ, Malow BA.

Sleep Med Clin. 2015 Jun;10(2):181-7. doi: 10.1016/j.jsmc.2015.02.008. Review.

9.

Sleep in Autism Spectrum Disorders.

Veatch OJ, Maxwell-Horn AC, Malow BA.

Curr Sleep Med Rep. 2015 Jun;1(2):131-140.

10.

Gastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiome.

Frye RE, Rose S, Slattery J, MacFabe DF.

Microb Ecol Health Dis. 2015 May 7;26:27458. doi: 10.3402/mehd.v26.27458.

11.

Approaches to studying and manipulating the enteric microbiome to improve autism symptoms.

Frye RE, Slattery J, MacFabe DF, Allen-Vercoe E, Parker W, Rodakis J, Adams JB, Krajmalnik-Brown R, Bolte E, Kahler S, Jennings J, James J, Cerniglia CE, Midtvedt T.

Microb Ecol Health Dis. 2015 May 7;26:26878. doi: 10.3402/mehd.v26.26878.

12.

Autism as a disorder of biological and behavioral rhythms: toward new therapeutic perspectives.

Tordjman S, Davlantis KS, Georgieff N, Geoffray MM, Speranza M, Anderson GM, Xavier J, Botbol M, Oriol C, Bellissant E, Vernay-Leconte J, Fougerou C, Hespel A, Tavenard A, Cohen D, Kermarrec S, Coulon N, Bonnot O, Dawson G.

Front Pediatr. 2015 Feb 23;3:1. doi: 10.3389/fped.2015.00001. Review.

13.

Influencing circadian and sleep-wake regulation for prevention and intervention in mood and anxiety disorders: what makes a good homeostat?

Frank E, Benabou M, Bentzley B, Bianchi M, Goldstein T, Konopka G, Maywood E, Pritchett D, Sheaves B, Thomas J.

Ann N Y Acad Sci. 2014 Dec;1334:1-25. doi: 10.1111/nyas.12600.

14.

The relationship between sleep and behavior in autism spectrum disorder (ASD): a review.

Cohen S, Conduit R, Lockley SW, Rajaratnam SM, Cornish KM.

J Neurodev Disord. 2014;6(1):44. doi: 10.1186/1866-1955-6-44. Review.

15.

The serotonin-N-acetylserotonin-melatonin pathway as a biomarker for autism spectrum disorders.

Pagan C, Delorme R, Callebert J, Goubran-Botros H, Amsellem F, Drouot X, Boudebesse C, Le Dudal K, Ngo-Nguyen N, Laouamri H, Gillberg C, Leboyer M, Bourgeron T, Launay JM.

Transl Psychiatry. 2014 Nov 11;4:e479. doi: 10.1038/tp.2014.120.

16.

Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders.

Laudon M, Frydman-Marom A.

Int J Mol Sci. 2014 Sep 9;15(9):15924-50. doi: 10.3390/ijms150915924. Review.

17.

Primary care for adults on the autism spectrum.

Nicolaidis C, Kripke CC, Raymaker D.

Med Clin North Am. 2014 Sep;98(5):1169-91. doi: 10.1016/j.mcna.2014.06.011. Review.

18.

Genetic variation in melatonin pathway enzymes in children with autism spectrum disorder and comorbid sleep onset delay.

Veatch OJ, Pendergast JS, Allen MJ, Leu RM, Johnson CH, Elsea SH, Malow BA.

J Autism Dev Disord. 2015 Jan;45(1):100-10. doi: 10.1007/s10803-014-2197-4.

19.

Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism.

Rossignol DA, Frye RE.

Front Physiol. 2014 Apr 22;5:150. doi: 10.3389/fphys.2014.00150. Review.

20.

Melatonin in children with autism spectrum disorders: endogenous and pharmacokinetic profiles in relation to sleep.

Goldman SE, Adkins KW, Calcutt MW, Carter MD, Goodpaster RL, Wang L, Shi Y, Burgess HJ, Hachey DL, Malow BA.

J Autism Dev Disord. 2014 Oct;44(10):2525-35. doi: 10.1007/s10803-014-2123-9.

Items per page

Supplemental Content

Support Center